These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 24183229)
1. Development of an Excel® spreadsheet to document disease activity in autoimmune bullous disease. Sebaratnam DF; Venugopa SS; Murrell DF Acta Dermatovenerol Croat; 2013; 21(3):207-8. PubMed ID: 24183229 [No Abstract] [Full Text] [Related]
2. Objective scoring systems for disease activity in autoimmune bullous disease. Sebaratnam DF; Murrell DF Dermatol Clin; 2011 Jul; 29(3):515-20, xi. PubMed ID: 21605820 [TBL] [Abstract][Full Text] [Related]
3. Severity score indexes for blistering diseases. Daniel BS; Hertl M; Werth VP; Eming R; Murrell DF Clin Dermatol; 2012; 30(1):108-13. PubMed ID: 22137234 [TBL] [Abstract][Full Text] [Related]
4. Achieving Diagnosis: Importance of Proper Biopsy in Autoimmune Bullous Disorders. Patel VM; Sylvester M; Baldev K; John AM; Lambert WC Skinmed; 2017; 15(2):129-131. PubMed ID: 28528608 [No Abstract] [Full Text] [Related]
5. [Immunopathology of autoimmune bullous dermatoses]. Prost C Ann Pathol; 1992; 12(4-5):276-83. PubMed ID: 1466684 [No Abstract] [Full Text] [Related]
6. [Analysis of infiltrating cells in the lesional skin of the autoimmune diseases-pemphigus, pemphigoid, and lupus erythematosus]. Hayakawa K Nihon Hifuka Gakkai Zasshi; 1988 Sep; 98(10):1023-8. PubMed ID: 3065535 [No Abstract] [Full Text] [Related]
7. A study of immunoperoxidase technique in the immunohistopathological diagnosis of autoimmune bullous diseases. Habib-ur-Rehman ; Ahmad M; Khan AA; Siraj QH; Ahmed SA J Pak Med Assoc; 1988 Jun; 38(6):154-8. PubMed ID: 3138468 [No Abstract] [Full Text] [Related]
8. Diffuse bullous eruption in a 3-month-old infant. Zebede MS; Anhalt GJ; Nsouli TM; Nsouli SM; Bellanti JA Ann Allergy; 1987 Jan; 58(1):12-3, 63-6. PubMed ID: 3541697 [No Abstract] [Full Text] [Related]
9. [Ultrastructural and immuno-electron-microscopic studies in linear IgA bullous dermatosis]. Dabrowski J; Chorzelski TP; Jabłońska S; Kraińska T; Jarzabek-Chorzelska M Przegl Dermatol; 1980; 67(5):541-8. PubMed ID: 7005970 [No Abstract] [Full Text] [Related]
10. Oral involvement in autoimmune bullous diseases. Ramos-e-Silva M; Ferreira A; Jacques Cd Clin Dermatol; 2011; 29(4):443-54. PubMed ID: 21679873 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis of autoimmune bullous skin diseases. Zillikens D Clin Lab; 2008; 54(11-12):491-503. PubMed ID: 19216255 [TBL] [Abstract][Full Text] [Related]
18. Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases. Pohla-Gubo G; Hintner H Dermatol Clin; 2011 Jul; 29(3):365-72, vii. PubMed ID: 21605801 [TBL] [Abstract][Full Text] [Related]
19. Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report. Cummings JE; Snyder RR; Kelly EB; Raimer SS Cutis; 2007 Mar; 79(3):203-7. PubMed ID: 17674585 [TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari. Atzori L; Deidda S; Aste N G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]